Quarterly report [Sections 13 or 15(d)]

Statements of Stockholders' Equity (Unaudited)

v3.25.2
Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Class A Preferred Shares
Preferred Stock
Class A Common Shares
Common Shares
Common Shares
Common Shares
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2023     $ 1 $ 591 $ 380,502 $ (380,971) $ 123
Balances (in shares) at Dec. 31, 2023 250,000 845,385 166,974        
Issuance of common shares - Founders Agreement       (591) 754   163
Issuance of common shares - Founders Agreement (in shares)     19,883        
Issuance of common shares, net of offering costs - Public Offerings         5,265   5,265
Issuance of common shares, net of offering costs - Public Offerings (in shares)     83,700        
Issuance of common shares under ESPP         48   48
Issuance of common shares under ESPP (in shares)     938        
Stock-based compensation expenses         (542)   (542)
Stock-based compensation expenses (in shares)     101        
Exercise of warrants     $ 2   1   3
Exercise of warrants (in shares)     409,816        
Net Loss           (13,390) (13,390)
Balances at Jun. 30, 2024     $ 3   386,028 (394,361) (8,330)
Balances (in shares) at Jun. 30, 2024 250,000 845,385 681,412        
Balances at Mar. 31, 2024     $ 1   381,218 (386,162) (4,943)
Balances (in shares) at Mar. 31, 2024 250,000 845,385 190,374        
Issuance of common shares - Founders Agreement         163   163
Issuance of common shares - Founders Agreement (in shares)     11,503        
Issuance of common shares, net of offering costs- Equity Offerings         5,265   5,265
Issuance of common shares, net of offering costs- Equity Offerings (in shares)     83,700        
Issuance of common shares under ESPP (in shares)     103        
Stock-based compensation expenses         (619)   (619)
Exercise of warrants     $ 2   1   3
Exercise of warrants (in shares)     395,732        
Net Loss           (8,199) (8,199)
Balances at Jun. 30, 2024     $ 3   386,028 (394,361) (8,330)
Balances (in shares) at Jun. 30, 2024 250,000 845,385 681,412        
Balances at Dec. 31, 2024     $ 5 611 392,234 (396,723) (3,873)
Balances (in shares) at Dec. 31, 2024 250,000 845,385 985,972        
Issuance of common shares - Founders Agreement       $ (611) 611    
Issuance of common shares - Founders Agreement (in shares)     69,046        
Issuance of common shares, equity fee on At-the-Market and equity offerings         216   216
Issuance of common shares, equity fee on At-the-Market and equity offerings (in shares)     67,806        
Issuance of common shares, net of offering costs- Equity Offerings         6,782   6,782
Issuance of common shares, net of offering costs- Equity Offerings (in shares)     495,000        
Issuance of common shares, net of offering costs - At-the-Market Offering         599   $ 599
Issuance of common shares, net of offering costs - At-the-Market Offering (in shares)     54,440        
Issuance of common shares under ESPP (in shares)     100       2,662
Stock-based compensation expenses         83   $ 83
Stock-based compensation expenses (in shares)     60        
Abeyance shares released (in shares)     185,880        
Exercise of warrants (in shares)     1,674,355        
Reverse Split (1-for-50) adjustment     $ (5)   5    
Reverse Split (1-for-50) adjustment (in shares)     (207)        
Net Loss           (915) (915)
Balances at Jun. 30, 2025         400,530 (397,638) 2,892
Balances (in shares) at Jun. 30, 2025 250,000 845,385 3,532,452        
Balances at Mar. 31, 2025         400,485 (396,876) 3,609
Balances (in shares) at Mar. 31, 2025 250,000 845,385 2,528,046        
Stock-based compensation expenses         45   45
Stock-based compensation expenses (in shares)     51        
Exercise of warrants (in shares)     1,004,355        
Net Loss           (762) (762)
Balances at Jun. 30, 2025         $ 400,530 $ (397,638) $ 2,892
Balances (in shares) at Jun. 30, 2025 250,000 845,385 3,532,452